Indolent B-Cell Lymphomas: Clinical Application of New Advances in Community Practice

Download this slideset from a local live webinar to learn how to optimally manage your patients with indolent lymphomas.

Elizabeth Brém, MD Christopher R. Flowers, MD, MS Released: June 21, 2022

Watch this on-demand webcast of a live webinar for expert discussion of how community practitioners can optimize therapy selection and manage treatment-related adverse events in patients with indolent B-cell lymphomas, such as marginal zone lymphoma and follicular lymphoma.

Elizabeth Brém, MD
Program Director Christopher R. Flowers, MD, MS
Program Director Pallawi Torka, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: August 3, 2022 Expired: August 2, 2023

Download this online resource developed for healthcare professionals with a helpful guide for antibody-based therapies in B-cell lymphoma.

Download this online resource developed to serve as a helpful guide for healthcare professionals on BTK inhibitors in B-cell lymphoma.

Download this online resource developed to serve as a helpful guide for healthcare professionals on investigational bispecific antibodies in indolent B-cell lymphomas.

Download this online resource developed to serve as a helpful guide for healthcare professionals on CAR T-cell therapies in B-cell lymphoma.

Download this online resource developed to serve as a helpful guide for healthcare professionals on IMiD therapy with lenalidomide in B-cell lymphomas.

Download this online resource developed to serve as a helpful guide for healthcare professionals on PI3K inhibitors in follicular and marginal zone lymphomas.

Download this online resource developed to serve as a helpful guide for healthcare professionals on tazemetostat and investigational epigenetic therapies in indolent B-cell lymphomas.